About Life Molecular Imaging
Life Molecular Imaging was founded in 2012 in Berlingerode, Germany, within the radiopharmaceutical sector. Novel PET tracers are developed and commercialized for molecular imaging applications. Focus is placed on early detection and characterization of neurodegenerative and cardiovascular diseases. The lead product supports Alzheimers diagnosis, while the research portfolio includes tracers for additional neurodegenerative conditions. Operations aim to enhance disease management through improved imaging tools.
- Headquarter Berlingerode, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Life Molecular Imaging Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Life Molecular Imaging
Unlock access to complete
Funding Insights of Life Molecular Imaging
Detailed funding history for Life Molecular Imaging
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Life Molecular Imaging
Life Molecular Imaging has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lantheus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of diagnostic imaging agents and targeted therapeutics
|
Locked | Locked | Locked |
Investor details for Life Molecular Imaging
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Life Molecular Imaging
Investment portfolio details for Life Molecular Imaging
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Life Molecular Imaging
Detailed financials for Life Molecular Imaging
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Life Molecular Imaging Comparisons
Peer comparison for Life Molecular Imaging
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Life Molecular Imaging
Detailed competitors of Life Molecular Imaging
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Life Molecular Imaging
Complete news archive for Life Molecular Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Life Molecular Imaging
Life Molecular Imaging was founded in 2012.
Life Molecular Imaging is headquartered in Berlingerode, Germany. It is registered at Berlingerode, Thuringen, Germany.
Ludger Dinkelborg is the current CEO of Life Molecular Imaging.
Life Molecular Imaging was founded in 2012 in Berlingerode, Germany, within the radiopharmaceutical sector. Novel PET tracers are developed and commercialized for molecular imaging applications. Focus is placed on early detection and characterization of neurodegenerative and cardiovascular diseases. The lead product supports Alzheimers diagnosis, while the research portfolio includes tracers for additional neurodegenerative conditions. Operations aim to enhance disease management through improved imaging tools.
Life Molecular Imaging has 1 investor. Key investors include Lantheus.